It started in Switzerland, a country also well known for the technical creativity.
Rudolf Greiner was such a person. He started with some brilliant ideas in the field of a typical Swiss domain, in the big and very successful watch making industry.
But after getting acquainted with the famous professor of clinical chemistry R.Richterich he changed into the field of medical diagnostics. The demand for analytical support in medicine was growing, and Richterich had the idea of an automation of the daily routine in a clinical lab.
To realize this idea into a working technical system was the part of Rudolf Greiner. So, finally in 1973 they launched the first automated and fully selective analyzer for clinical chemistry, the GSA. And since today that principle is still the bases of all modern clinical analyzers.
The following years were a story of growth and success, and the Greiner company and its business grew, too. They developed more and bigger machines, but parallel to the technical part there was also another improvement, namely that of the needed reagents:
It was quite important that the reagents were simple to handle and had a good stability. That was the birth of the “Greiner reagents”.
But many years later in 1990 there was a break in the Greiner history. Through heavy competition for example from Japanese manufacturers the Greiner instrument production went down and finally in 1990 had to stop. The analyzer business became “frozen”. The manufacturing of reagents however continue and in 2004 even made a step forward again, when the German Greiner GmbH was founded in Bahlingen, southern Germany.
A group of experience people from the medical diagnostic field started the production and the marketing of reagents, especially liquid ones, under the Greiner label, but also for numerous so called OEM customers.
And, finally, the sleeping instrument domain woke up again: now there is a cooperation with external technical partners, for a common development of Greiner brand instruments.
And there is still the idea of an innovative clinical chemistry analyser, the "GFA" This will probably be made and launched with an investor partner.